| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-105831
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 |
| filingDate |
2008-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ee0f3978abc44cede9979796f9d4632
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4738ab2314eace3a4be8c3b1e1bf6e0b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13860e061f997b0ee474cf85ed94d43e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbef54fcf1ae9a701c3cad44e4b05d1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23ee148b76736b941b2fa787549b41a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4206d0235a60c03abd580a736e7fb9d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_717c900a1d80960e0b308a6cd1b6bc84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33345780717878c3783108dbe30fa16b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bb56a8ef55a6c459b3f6d290a0a578b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6d23a70c05a3f68d7cbcf2c195e5b0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4721fc91c6fcb34fdf9fecc91fc42d70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6b92e20be1c1f6483332869555c6592
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3ce4eb1470d397ea45ddc658902b53b |
| publicationDate |
2016-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2702612-C |
| titleOfInvention |
Antibodies that bind to mammalian ngal and uses thereof |
| abstract |
The present invention relates to antibodies specific for glycosylated mammalian NGAL, and to methods of making and using such antibodies. |
| priorityDate |
2007-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |